Source: Pexels (Chokniti Kongchum)
- Pfizer has announced that they expect to have a coronavirus vaccine ready for "emergency use" by the fall of this year.
- Their coronavirus vaccine is expected to begin human trials next week in the United States.
- The vaccine has already begun clinical trials on humans in Germany via BioNtech.
- Pfizer has invested over 650 million into developing the vaccine.
We'd love to help you learn more about what's happening